Sage Therapeutic Stock Price Prediction
| SAGE Stock | USD 13.04 0.47 3.74% |
Oversold Vs Overbought
22
Oversold | Overbought |
Sage Therapeutic stock price prediction is an act of determining the future value of Sage Therapeutic shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Sage Therapeutic's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Sage Therapeutic and does not consider all of the tangible or intangible factors available from Sage Therapeutic's fundamental data. We analyze noise-free headlines and recent hype associated with Sage Therapeutic, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Sage Therapeutic's stock price prediction:EPS Estimate Next Quarter (1.46) | EPS Estimate Current Year (6.40) | EPS Estimate Next Year (4.86) | Wall Street Target Price 26 | EPS Estimate Current Quarter (1.28) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Sage Therapeutic based on different types of headlines from major news networks to social media. The Sage stock price prediction module provides an analysis of price elasticity to changes in media outlook on Sage Therapeutic over a specific investment horizon. Using Sage Therapeutic hype-based prediction, you can estimate the value of Sage Therapeutic from the perspective of Sage Therapeutic response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Sage Therapeutic using Sage Therapeutic's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Sage using crowd psychology based on the activity and movement of Sage Therapeutic's stock price.
Sage Therapeutic Short Interest
A significant increase or decrease in Sage Therapeutic's short interest from the previous month could be a good indicator of investor sentiment towards Sage. Short interest can provide insight into the potential direction of Sage Therapeutic stock and how bullish or bearish investors feel about the market overall. An investor who is long Sage Therapeutic may also wish to track short interest. As short interest increases, investors should be becoming more worried about Sage Therapeutic and may potentially protect profits, hedge Sage Therapeutic with its derivative instruments, or be ready for some potential downside.
200 Day MA 23.4266 | Short Percent 0.2159 | Short Ratio 10.28 | Shares Short Prior Month 8.4 M | 50 Day MA 20.1952 |
Sage Therapeutic Hype to Price Pattern
Investor biases related to Sage Therapeutic's public news can be used to forecast risks associated with an investment in Sage. The trend in average sentiment can be used to explain how an investor holding Sage can time the market purely based on public headlines and social activities around Sage Therapeutic. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Sage Therapeutic's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Sage Therapeutic.
Sage Therapeutic Implied Volatility | 222.26 |
Sage Therapeutic's implied volatility exposes the market's sentiment of Sage Therapeutic stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Sage Therapeutic's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Sage Therapeutic stock will not fluctuate a lot when Sage Therapeutic's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Sage Therapeutic. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Sage Therapeutic to buy its stock at a price that has no basis in reality. In that case, they are not buying Sage because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Sage Therapeutic after-hype prediction price | USD 12.66 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sage |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sage Therapeutic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Sage Therapeutic After-Hype Price Prediction Density Analysis
As far as predicting the price of Sage Therapeutic at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sage Therapeutic or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sage Therapeutic, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sage Therapeutic Estimiated After-Hype Price Volatility
In the context of predicting Sage Therapeutic's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sage Therapeutic's historical news coverage. Sage Therapeutic's after-hype downside and upside margins for the prediction period are 8.89 and 16.43, respectively. We have considered Sage Therapeutic's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sage Therapeutic is not too volatile at this time. Analysis and calculation of next after-hype price of Sage Therapeutic is based on 3 months time horizon.
Sage Therapeutic Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Sage Therapeutic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sage Therapeutic backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sage Therapeutic, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.03 | 3.77 | 0.38 | 0.19 | 10 Events / Month | 15 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
13.04 | 12.66 | 2.91 |
|
Sage Therapeutic Hype Timeline
Sage Therapeutic is at this time traded for 13.04. The entity has historical hype elasticity of -0.38, and average elasticity to hype of competition of 0.19. Sage is forecasted to decline in value after the next headline, with the price expected to drop to 12.66. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.91%, whereas the daily expected return is at this time at -1.03%. The volatility of related hype on Sage Therapeutic is about 1998.55%, with the expected price after the next announcement by competition of 13.23. About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.16. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sage Therapeutic has Price/Earnings To Growth (PEG) ratio of 0.74. The entity recorded a loss per share of 9.05. The firm had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Sage Therapeutic Basic Forecasting Models to cross-verify your projections.Sage Therapeutic Related Hype Analysis
Having access to credible news sources related to Sage Therapeutic's direct competition is more important than ever and may enhance your ability to predict Sage Therapeutic's future price movements. Getting to know how Sage Therapeutic's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sage Therapeutic may potentially react to the hype associated with one of its peers.
Sage Therapeutic Additional Predictive Modules
Most predictive techniques to examine Sage price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sage using various technical indicators. When you analyze Sage charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sage Therapeutic Predictive Indicators
The successful prediction of Sage Therapeutic stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sage Therapeutic, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sage Therapeutic based on analysis of Sage Therapeutic hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sage Therapeutic's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sage Therapeutic's related companies. | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.001427 | 0.001284 | 0.001238 | Price To Sales Ratio | 294.29 | 15.0 | 14.25 |
Story Coverage note for Sage Therapeutic
The number of cover stories for Sage Therapeutic depends on current market conditions and Sage Therapeutic's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sage Therapeutic is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sage Therapeutic's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Sage Therapeutic Short Properties
Sage Therapeutic's future price predictability will typically decrease when Sage Therapeutic's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sage Therapeutic often depends not only on the future outlook of the potential Sage Therapeutic's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sage Therapeutic's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 59.8 M | |
| Cash And Short Term Investments | 753.2 M |
Check out Sage Therapeutic Basic Forecasting Models to cross-verify your projections. For information on how to trade Sage Stock refer to our How to Trade Sage Stock guide.Note that the Sage Therapeutic information on this page should be used as a complementary analysis to other Sage Therapeutic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Sage Stock analysis
When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Sage Therapeutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sage Therapeutic. If investors know Sage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sage Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.05) | Revenue Per Share 1.445 | Quarterly Revenue Growth 26.215 | Return On Assets (0.31) | Return On Equity (0.53) |
The market value of Sage Therapeutic is measured differently than its book value, which is the value of Sage that is recorded on the company's balance sheet. Investors also form their own opinion of Sage Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Sage Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sage Therapeutic's market value can be influenced by many factors that don't directly affect Sage Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sage Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sage Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sage Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.